A Role of Cytokines in OK-432 Injection Therapy for Cystic Lymphangioma: An Approach to the Mechanism

Akihiro Fujino, Yoichiro Moriya, Yasuhide Morikawa, Ken Hoshino, Toshihiko Watanabe, Naoki Shimojima, Masaki Kitajima

研究成果: Article査読

37 被引用数 (Scopus)

抄録

Purpose: This study examines cytokine levels of aspirates from cystic lymphangiomas after injection of OK-432 and over the course of several weeks to better understand the process of tumor regression. Methods: Fluids aspirated from lymphangioma cysts of 3 patients were collected sequentially before and after OK-432 injection. Mononuclear cells (MNCs) were separated and cultured with or without OK-432. Vascular endothelial growth factor (VEGF), soluble VEGF receptor 1 (sVEGFR1), sVEGFR2, transforming growth factor beta-1 (TGF-β1), interleukin (IL)-6, IL-8, IL-12+p40, tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ) levels in the supernatants of the aspirates and the culture supernatants of MNCs were then measured by ELISA. Results: The aspirates exhibited a marked elevation in IL-6, IL-8, VEGF, and TGF-β1 levels for a few weeks after the OK-432 injection. IL-6, IL-8, IL-12+p40, TNF-α, and IFN-γ levels were elevated in the culture supernatants of the MNC cultured with OK-432 for up to 9 days. All the tumors regressed significantly, with sclerotic change, within 3 months after OK-432 Injection. Conclusions: Cytokine production is maintained for a few weeks after OK-432 injection. Fibrotic changes may be another main mechanism in tumor regression in addition to cytotoxic effects on lymphangioma cells. A close relationship between cytokines from intracystic cells and lymphangioma cells is suggested.

本文言語English
ページ(範囲)1806-1809
ページ数4
ジャーナルJournal of Pediatric Surgery
38
12
DOI
出版ステータスPublished - 2003 12

ASJC Scopus subject areas

  • 外科
  • 小児科学、周産期医学および子どもの健康

フィンガープリント

「A Role of Cytokines in OK-432 Injection Therapy for Cystic Lymphangioma: An Approach to the Mechanism」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル